Brugada syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Risk Statification== | ==Risk Statification== | ||
* Patients with syncope and an abnormal Type 1 ECG are at higher risk | * Patients with syncope and an abnormal Type 1 ECG are at higher risk | ||
* Asymptomatic patients at risk can be identified | * Asymptomatic patients at risk can be identified | ||
Line 17: | Line 16: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Electrophysiology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 23:52, 13 October 2012
Brugada syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Brugada syndrome risk factors On the Web |
American Roentgen Ray Society Images of Brugada syndrome risk factors |
Risk calculators and risk factors for Brugada syndrome risk factors |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk Statification
- Patients with syncope and an abnormal Type 1 ECG are at higher risk
- Asymptomatic patients at risk can be identified
- Presence of spontaneous Type 1 ST-segment elevation
- Characteristics of the S wave
- Presence of late potentials
- Inducibility of VT/VF using PES.